Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure

Clinical and Experimental Allergy

Volumn 27, Issue 10, 1997, Pages 1145-1150

  Park, H S ^a   Nahm, D H ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Occupational asthma; Prognosis; TDI

Indexed keywords

ANTIASTHMATIC AGENT; STEROID; TOLUENE DIISOCYANATE;

ADULT; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; STEROID THERAPY;

ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; LONGITUDINAL STUDIES; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; OCCUPATIONAL DISEASES; PROGNOSIS; SMOKING; STEROIDS; TOLUENE 2,4-DIISOCYANATE;

EID: 0030819483     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01151.x     Document Type: Article

References (18)

1. Park HS, Park JN, Kim JW, Kim SK. Clinical and immunological evaluation of isocyanate-exposed workers. J Kor Med Sci 1992; 7:122-7.
2. Paggiaro PL, Loi AM, Rosso O et al. Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI). Clin Allergy 1984; 14:463-9.
3. Losewicz S, Assoufi BK, Hawkins R, Newman Taylor AJ. Outcome of asthma induced by isocyanates. Br J Dis Chest 1987; 81:14-22.
4. Mapp CE, Chieura P, Marzo ND, Fabbri L. Persistent asthma due to isocyanate. Am Rev Respir Dis 1988; 137:1362-9.
5. Pisati G, Baruffini A, Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br J Ind Med 1992; 50:60-4.
6. Banks DE, Rando RJ, Barkman HW, Jr. Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposure. Chest 1990; 97:121-5.
7. Paggiaro P, Bacci E, Dente F, Talni D, Giuntini C. Prognosis of occupational asthma induced by isocyanates. Bull Eur Physiopathol Respir 1988; 23:565-9.
8. Rosenberg N, Gamier R, Rousselin X, Mertz R, Gervais P. Clinical and socio-professional fate of isocyanate-induced asthma. Clin Allergy 1987; 17:55-61.
9. Paggiaro PL, Vagaggini B, Dente FL et al. Bronchial hyperresponsiveness and toluene diisocyanate. Long term change in sensitized asthmatic subjects. Chest 1993; 103:1123-8.
10. Park HS, Lee MK, Kim BO et al. Clinical and immunological evaluation of reactive dye exposed worker. J Allergy Clin Immunol 1991; 87:639-49.
11. Perrin B, Cartier A, Ghezzo H et al. Reassessment of the temporal pattern of bronchial obstruction after exposure to occupational sensitizing agent. J Allergy Clin Immunol 1991; 87:630-9.
12. Baur X, Dewair M, Frushmann G. Detection of immunologically sensitized isocyanate workers by RAST and intracutaneous skin tests. J Allergy Clin Immunol 1984; 73:610-8.
13. Baur X, Fruhamnn G. Specific IgE antibodies in patients with isocyanate asthma. Chest 1981; 80(suppl):73-6.
14. Malo JL, Gartier A, Ghezzo H et al. Patterns of improvement in spirometry bronchial hyperresponsiveness and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am Rev Respir Dis 1988; 136:807-12.
15. Chan-Yeung M. A clinician's approach to determine the diagnosis, prognosis, and therapy of occupational asthma. Med Clin of N Am 1990; 74:811-22.
16. Maestrelli P, De-Marzzo N, Saetta M et al. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo-controlled study of subjects sensitized to toluene diisocyanate. Am Rev Respir Dis 1993; 148:407-12.
17. Paggiaro PL, Bacci VE, Bancalari L et al. Prognosis of occupational asthma. Eur Respir J 1994; 7:761-7.
18. Park HS, Nahm DH. Isocyanate-induced occupational asthma: Immunologic and challenge studies. J Kor Med Sci 1996; 11:314-8.